UK begins trials of Ebola vaccine developed in just eight weeks
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
Reporting preview
Researcher Alex Sampson holds the experimental Ebola vaccine
A new vaccine to tackle Ebola will now be tested on people after the UK regulator gave permission for trials to take place.
Scientists at the University of Oxford started developing the vaccine eight weeks ago when a public health emergency was declared on 17 May.
It is the first - out of four vaccines under development - to enter clinical trials.
Volunteers are being recruited, with the first doses expected to be given to healthy adults in the UK "within weeks".
This preview is a source-linked editorial excerpt. Continue to the original publisher for the complete report, updates and full context.